APA (7th ed.) Citation

AA, A., DS, E., R, E., M, S., R, A., O, K., . . . MY, Z. (2023). Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: In vitro and in silico studies. Journal of enzyme inhibition and medicinal chemistry, 38(1), 2202357. https://doi.org/10.1080/14756366.2023.2202357

Chicago Style (17th ed.) Citation

AA, Al-Karmalawy, et al. "Design and Statistical Optimisation of Emulsomal Nanoparticles for Improved Anti-SARS-CoV-2 Activity of N-(5-nitrothiazol-2-yl)-carboxamido Candidates: In vitro and in Silico Studies." Journal of Enzyme Inhibition and Medicinal Chemistry 38, no. 1 (2023): 2202357. https://doi.org/10.1080/14756366.2023.2202357.

MLA (9th ed.) Citation

AA, Al-Karmalawy, et al. "Design and Statistical Optimisation of Emulsomal Nanoparticles for Improved Anti-SARS-CoV-2 Activity of N-(5-nitrothiazol-2-yl)-carboxamido Candidates: In vitro and in Silico Studies." Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 38, no. 1, 2023, p. 2202357, https://doi.org/10.1080/14756366.2023.2202357.